PLASMA IDOL, SOLUBLE LDLR AND PCSK9 LEVELS AS POTENTIAL BIOMARKERS OF FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDREN

被引：0
|
作者：
Girona, J. [1 ]
Rodriguez-Borjabad, C. [2 ]
Ibarretxe, D. [2 ]
Heras, M. [1 ]
Amigo, N. [3 ]
Feliu, A. [4 ]
Masana, L. [1 ,2 ]
Plana, N. [2 ]
机构：
[1] URV, CIBERDEM, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain
[2] URV, St Joan Univ Hosp, CIBERDEM, IISPV,Vasc Med & Metab Unit, Reus, Spain
[3] URV, CIBERDEM, IISPV, Biosfer Teslab, Reus, Spain
[4] Univ Rovira & Virgili, IISPV, Pediat Res Unit, Reus, Spain
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAG3.3
引用
收藏
页码：E22 / E22
页数：1
相关论文
共 50 条
  • [21] A CASE FOR PCSK9 INHIBITORS IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Arnold, Claire
    Stephenson, Christopher
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S574 - S575
  • [22] Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia
    Baass, Alexis
    Hegele, Robert A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (08) : 959 - 961
  • [23] The Molecular Basis of Familial Hypercholesterolemia in Lebanon: Spectrum of LDLR Mutations and Role of PCSK9 as a Modifier Gene
    Abifadel, Marianne
    Rabes, Jean-Pierre
    Jambart, Selim
    Halaby, Georges
    Gannage-Yared, Marie-Helene
    Sarkis, Antoine
    Beaino, Ghada
    Varret, Mathilde
    Salem, Nabiha
    Corbani, Sandra
    Aydenian, Hermine
    Junien, Claudine
    Munnich, Arnold
    Boileau, Catherine
    HUMAN MUTATION, 2009, 30 (07) : E682 - E691
  • [24] Familial hypercholesterolemia: Is there a role for PCSK9 and thrombin generation?
    Silvino, J. P. P. .
    Carvalho, M. G.
    Reis, E. A.
    Mota, A. P. L.
    Gomes, K. B.
    Duarte, R. C. F.
    Guimaraes, M. C. J.
    Sousa, M. C. R.
    Azevedo, P. S.
    Silva, I. F. O.
    THROMBOSIS RESEARCH, 2021, 200 : 156 - 163
  • [25] Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
    Tomlinson, Brian
    Patil, Nivritti Gajanan
    Fok, Manson
    Lam, Christopher Wai Kei
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (02) : 279 - 295
  • [26] Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis
    Chora, Joana Rita
    Medeiros, Ana Margarida
    Alves, Ana Catarina
    Bourbon, Mafalda
    GENETICS IN MEDICINE, 2018, 20 (06) : 591 - 598
  • [27] The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
    Jean-Philippe Drouin-Chartier
    Jean-Charles Hogue
    André J. Tremblay
    Jean Bergeron
    Benoît Lamarche
    Patrick Couture
    Lipids in Health and Disease, 16
  • [28] The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
    Drouin-Chartier, Jean-Philippe
    Hogue, Jean-Charles
    Tremblay, Andre J.
    Bergeron, Jean
    Lamarche, Benoit
    Couture, Patrick
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [29] Genetic Polymorphisms in LDLR, APOB, PCSK9 and Other Lipid Related Genes Associated with Familial Hypercholesterolemia in Malaysia
    Lye, Say-Hean
    Chahil, Jagdish Kaur
    Bagali, Pramod
    Alex, Livy
    Vadivelu, Jamunarani
    Ahmad, Wan Azman Wan
    Chan, Siew-Pheng
    Thong, Meow-Keong
    Zain, Shamsul Mohd
    Mohamed, Rosmawati
    PLOS ONE, 2013, 8 (04):
  • [30] Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
    Doi, Takahito
    Hori, Mika
    Harada-Shiba, Mariko
    Kataoka, Yu
    Onozuka, Daisuke
    Nishimura, Kunihiro
    Nishikawa, Ryo
    Tsuda, Kosuke
    Ogura, Masatsune
    Son, Cheol
    Miyamoto, Yoshihiro
    Noguchi, Teruo
    Shimokawa, Hiroaki
    Yasuda, Satoshi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (04): : 1 - 11
12345